123 completed, 38 unknown, 11 terminated, 6 not yet recruiting. 70 Phase 3, 66 Phase 2, 24 Phase 4, 23 Not applicable, 23 Phase 1.
Follow Ivermectin: new trials by email Literature Review of Ivermectin trials Research Report on Ivermectin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Ivermectin Pill - Atopic Dermatitis | Phase 2 | Withdrawn | Stanford University | 2030-12-01 | 2024-12-02 | |
| Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC) Intermediate-dose ivermectin, High-dose ivermectin - Solid Tumor, Adult | Phase 2 | Not yet recruiting | University of Florida | 80 | 2026-12-01 | 2026-10-13 |
| Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras Placebo, Albendazole 400 mg, Albendazole Plus Ivermectin - Trichuriasis, Strongyloidiasis | Phase 3 | Not yet recruiting | Mundo Sano Foundation | 368 | 2026-11-01 | 2026-06-23 |
| Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks Topical anti-aging peptide serum - Aging | Early Phase 1 | Enrolling by invitation | Frontiers in Bioscience Research Institute and Aging | 48 | 2026-10-21 | 2026-10-22 |
| Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in Uganda Albendazole 400mg, Ivermectin 3 mg - Ascariasis | Phase 3 | Not yet recruiting | Jennifer Keiser | 450 | 2026-10-01 | 2026-10-14 |
| Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma Ivermectin - Survival of Flies Developing in Faecal Samples | Phase 4 | Not yet recruiting | London School of Hygiene and Tropical Medicine | 12 | 2026-07-01 | 2026-06-18 |
| Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations Modified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg - Onchocerciasis (River Blindness), Schistosomiasis | Not applicable | Recruiting | Uwemedimo Friday Ekpo | 5760 | 2026-07-01 | 2026-07-16 |
| the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts. Ivermectin, microneedling, Salicylic Acid - Warts | Early Phase 1 | Not yet recruiting | Assiut University | 88 | 2026-02-01 | 2026-02-09 |
| Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection | Phase 4 | Recruiting | Kirby Institute | 52000 | 2025-08-04 | 2025-11-21 |
| Assessing the Safety and Efficacy of a Combination Therapy for STH in PSAC in Bangladesh A single dose of Albendazole 400mg + Ivermectin (200 µg/ kg) combination therapy, A single dose of 400 mg Oral Albendazole monotherapy - Soil Transmitted Helminth (STH) Infections | Phase 2 | Enrolling by invitation | International Centre for Diarrhoeal Disease Research, Bangladesh | 110 | 2025-07-10 | 2025-08-14 |
| Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) Ivermectin Tablets - Scabies; Itch, Scabies | Phase 2 | Active not recruiting | Murdoch Childrens Research Institute | 120 | 2025-06-24 | 2026-10-16 |
| Efficacy of Ivermectin in the Treatment of Plane Warts Ivermectin, Placebo - Plane Warts | Phase 2 | Completed | Al-Azhar University | 80 | 2025-06-01 | 2026-10-09 |
| Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies Permethrin Cream, 5%, Ivermectin 200 µg/kg - Scabies | Phase 2 | Not yet recruiting | Children Hospital and Institute of Child Health, Lahore | 90 | 2025-05-01 | 2025-04-20 |
| Co-administration of IVM and ALB in School-based Deworming in Uganda Albendazole 400mg, Ivermectin 3 MG - Helminthiasis, Intestinal Worms | Completed | Jennifer Keiser | 8767 | 2024-07-01 | 2024-12-20 | |
| Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis | Phase 2 | Completed | Jennifer Keiser | 260 | 2024-06-05 | 2025-09-22 |
| Specific Versus Empirical Anthelminthic Treatment in Eosinophilia Albendazole, Ivermectin or albendazole - Eosinophilia | Not applicable | Unknown | Prince of Songkla University | 700 | 2024-05-01 | 2024-09-24 |
| Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis Ivermectin w/ Albendazole, Ivermectin + Diethylcarbamazine + Albendazole, Moxidectin + Albendazole - Onchocercal Subcutaneous Nodule, Onchocerciasis | Phase 2 | Active not recruiting | Washington University School of Medicine | 300 | 2024-04-05 | 2025-12-18 |
| Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream Ivermectin cream, Soolantra ® (Ivermectin) cream - Rosacea | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 44 | 2024-03-06 | 2024-08-20 |
| Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand Oral Ivermectin, 4% dimenticone liquid gel - Pediculus Capitis Infestation, Permethrin Adverse Reaction | Phase 4 | Unknown | Phramongkutklao College of Medicine and Hospital | 117 | 2023-12-15 | 2024-03-27 |
| Ivermectin Safety in Small Children Oral ivermectin, Permethrin Cream, Placebo tablet - Scabies | Phase 2 | Completed | University of Oxford | 240 | 2023-11-18 | 2025-12-18 |
Showing 20 of 195. Sign in to see all of them.
COVID-19 (68) · Elephantiasis, Filarial (17) · Onchocerciasis (13) · Scabies (13) · Coronavirus Infections (10) · Malaria (10) · Rosacea (9) · Trichuriasis (8) · Helminthiasis (7) · Severe Acute Respiratory Syndrome (7) · Neglected Diseases (6) · Onchocerciasis, Ocular (6) · Strongyloidiasis (6) · Ascariasis (5) · Hookworm Infections (5)
Jennifer Keiser (9) · London School of Hygiene and Tropical Medicine (8) · Washington University School of Medicine (6) · Mahidol University (5) · Galderma R&D (4) · International Centre for Diarrhoeal Disease Research, Bangladesh (4) · Johnson & Johnson Consumer and Personal Products Worldwide (4) · Medicines Development for Global Health (4) · Tanta University (4) · University Hospitals Cleveland Medical Center (4) · Assiut University (3) · DBL -Institute for Health Research and Development (3) · Susanna Naggie, MD (3) · University of Oxford (3) · Ain Shams University (2)
United States (26) · Egypt (17) · Thailand (12) · Pakistan (9) · Argentina (8) · Côte d’Ivoire (8) · Uganda (7) · Bangladesh (6) · Democratic Republic of the Congo (6) · France (6) · Ghana (6) · United Kingdom (6) · Brazil (5) · Colombia (5) · Burkina Faso (4)
Jerry Cottrell (4) · Adrian Hernandez, MD (3) · Susanna Naggie, MD (3) · Benjamin Koudou, PhD (2) · Brian D. Foy, PhD (2) · Gary J Weil, MD (2) · Gary Weil, MD (2) · Jennifer Keiser, Prof. (2) · Peter U Fischer, PhD (2) · Tony Ukety, MD, DO, MPH (2) · Yupin Suputtamongkol, MD (2) · Aboulaye Miete, MD (1) · Adrian J Wolstenholme, PhD (1)
PMID 32251768, PMID 42848323, PMID 23675549, PMID 32293834, PMID 33227231, PMID 33234158, PMID 34473343, PMID 35180412, PMID 37262040, PMID 37489818, PMID 37949090, PMID 39308445, PMID 39356094, PMID 12474486, PMID 12592987, PMID 15992957, PMID 16103202, PMID 16287208, PMID 16681635, PMID 16713738, PMID 17399779, PMID 17426180, PMID 18414647, PMID 18446504, PMID 18564693, PMID 18809192, PMID 19081121, PMID 19265242, PMID 19571614, PMID 19589144, PMID 20220184, PMID 21353271, PMID 21572981, PMID 21885077, PMID 22073495, PMID 22417684, PMID 23647969, PMID 23769930, PMID 23981378, PMID 24161512, PMID 24968000, PMID 25108173, PMID 25877874, PMID 26393130, PMID 26401658, PMID 26486704, PMID 26744590, PMID 26752081, PMID 26827134, PMID 26988202
U24TR001608 (3), 2015 (1), 2023 (1), U01AI138910 (1), UL1TR000124 (1)